Gan Chuo Clinic’s “cancer photoimmunotherapy” and the head and neck cancer treatment approved in Japan use different drugs. Here is how to tell them apart.
In Japan the name “photoimmunotherapy” is used by several institutions. Check the drug, device and approval status before the name.
How to tell them apart
- Drug: cetuximab sarotalocan sodium, or ICG liposomes and talaporfin liposomes?
- Approval: the head and neck cancer treatment given conditional early approval in 2020, or a method the clinic says includes unapproved drugs or devices?
- Insurance: the clinic states its own method is not covered by public insurance.
Cost information
Gan Chuo Clinic posts ¥2,200,000 per course (five visits, about one month), tax included (checked 12 October 2026).
What to ask the medical team
Asking first for “the exact name and approval status of the drug used” is the clearest way to check.
Photoimmunotherapy-related Information in Japan
Source links and check date
- がん中央クリニックグループ「がん光免疫療法」(スーパーライザーEX)
https://chuoclinic.jp/photoimmunotherapy/
Checked on: 2026-10-12
FTH is not a medical institution; it is a company that provides guidance on overseas medical information, translation, and on-site interpretation support. The content of this site is for informational purposes only and does not constitute a diagnosis or treatment recommendation for any individual, nor a guarantee of treatment results. Please discuss the suitability, risks and decision to undergo any treatment with your attending medical team.
